Top Markets
#1 Pleasing Gold Pleasing Gold +1,501.42%
#2 PulseChain PulseChain +58.12%
#3 Ontology Gas Ontology Gas +39.42%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.22%
#5 BOOK OF MEME BOOK OF MEME +30.74%
#6 Neiro Neiro +27.65%
#7 ConstitutionDAO ConstitutionDAO +27.64%
#8 Pump.fun Pump.fun +25.65%
#9 Unit Pump Unit Pump +25.65%
#10 Collect on Fanable Collect on Fanable +24.61%
Coin of the day
Pleasing Gold Pleasing Gold
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
Kedudukan dalam Saham #26168
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
Harga Saham
$1.73
Modal Pasaran
$42.88M
Perubahan (1 hari)
2.16%
Perubahan (1 tahun)
-18.85%
Negara
PL
Perdagangan Molecure S.A. (MOC)

Kategori

Healthcare
Hasil untuk Molecure S.A. (MOC)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Molecure S.A., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Molecure S.A. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH